These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 23747891

  • 1. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
    Li C, Shi X, Zhou G, Liu X, Wu S, Zhao J.
    Front Biosci (Landmark Ed); 2013 Jun 01; 18(4):1384-91. PubMed ID: 23747891
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
    Ma Y, Ren Y, Han EQ, Li H, Chen D, Jacobs JJ, Gitelis S, O'Keefe RJ, Konttinen YT, Yin G, Li TF.
    Biochem Biophys Res Commun; 2013 Feb 08; 431(2):274-9. PubMed ID: 23291185
    [Abstract] [Full Text] [Related]

  • 3. Wnt signaling in osteosarcoma.
    Lin CH, Ji T, Chen CF, Hoang BH.
    Adv Exp Med Biol; 2014 Feb 08; 804():33-45. PubMed ID: 24924167
    [Abstract] [Full Text] [Related]

  • 4. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
    Liu Y, Wang W, Xu J, Li L, Dong Q, Shi Q, Zuo G, Zhou L, Weng Y, Tang M, He T, Luo J.
    Oncol Rep; 2013 Oct 08; 30(4):1723-30. PubMed ID: 23917613
    [Abstract] [Full Text] [Related]

  • 5. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M, Rainusso N, Lee YC, Dawson B, Coarfa C, Han R, Larson JL, Shuck R, Kurenbekova L, Yustein JT.
    J Natl Cancer Inst; 2019 Nov 01; 111(11):1216-1227. PubMed ID: 30793158
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y, Zhu B, Liu X, Yu H, Yong L, Liu X, Shao J, Liu Z.
    J Exp Clin Cancer Res; 2015 Oct 06; 34():115. PubMed ID: 26444270
    [Abstract] [Full Text] [Related]

  • 7. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling.
    Jiang C, He C, Wu Z, Li F, Xiao J.
    Biochem Biophys Res Commun; 2018 Jul 20; 502(3):382-388. PubMed ID: 29842882
    [Abstract] [Full Text] [Related]

  • 8. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
    Cai Y, Mohseny AB, Karperien M, Hogendoorn PC, Zhou G, Cleton-Jansen AM.
    J Pathol; 2010 Jan 20; 220(1):24-33. PubMed ID: 19882675
    [Abstract] [Full Text] [Related]

  • 9. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A, Zhang Z, Zhou Y, Li X, Li X, Ma B, Zhang Q.
    Phytomedicine; 2020 Apr 20; 69():153183. PubMed ID: 32113150
    [Abstract] [Full Text] [Related]

  • 10. Targeting WNT5B and WNT10B in osteosarcoma.
    Miranda-Carboni GA, Krum SA.
    Oncotarget; 2024 Aug 02; 15():535-540. PubMed ID: 39102216
    [Abstract] [Full Text] [Related]

  • 11. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
    Wu BQ, Cao Y, Bi ZG.
    Eur Rev Med Pharmacol Sci; 2017 Jul 02; 21(14):3185-3192. PubMed ID: 28770967
    [Abstract] [Full Text] [Related]

  • 12. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
    Zhao SJ, Jiang YQ, Xu NW, Li Q, Zhang Q, Wang SY, Li J, Wang YH, Zhang YL, Jiang SH, Wang YJ, Huang YJ, Zhang XX, Tian GA, Zhang CC, Lv YY, Dai M, Liu F, Zhang R, Zhou D, Zhang ZG.
    Oncogene; 2018 Feb 22; 37(8):1049-1061. PubMed ID: 29084211
    [Abstract] [Full Text] [Related]

  • 13. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
    Chang J, Li Y, Wang X, Hu S, Wang H, Shi Q, Wang Y, Yang Y.
    Sci Rep; 2017 Aug 08; 7(1):7605. PubMed ID: 28790389
    [Abstract] [Full Text] [Related]

  • 14. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
    Leow PC, Bahety P, Boon CP, Lee CY, Tan KL, Yang T, Ee PL.
    Eur J Med Chem; 2014 Jan 08; 71():67-80. PubMed ID: 24275249
    [Abstract] [Full Text] [Related]

  • 15. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z, Jiang C, Fang J.
    Biochem Biophys Res Commun; 2018 Jan 01; 495(1):238-245. PubMed ID: 29108989
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of Sox2 Inhibits OS Cells Invasion and Migration via Modulating Wnt/β-Catenin Signaling Pathway.
    Tang L, Wang D, Gu D.
    Pathol Oncol Res; 2018 Oct 01; 24(4):907-913. PubMed ID: 29619662
    [Abstract] [Full Text] [Related]

  • 17. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B, Cheng D, Li S, Zhou S, Yang Q.
    Int J Mol Sci; 2016 Jul 22; 17(7):. PubMed ID: 27455247
    [Abstract] [Full Text] [Related]

  • 18. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics.
    Fuloria S, Yadav G, Menon SV, Ali H, Pant K, Kaur M, Deorari M, Sekar M, Narain K, Kumar S, Fuloria NK.
    Pathol Res Pract; 2024 Jul 22; 259():155346. PubMed ID: 38781762
    [Abstract] [Full Text] [Related]

  • 19. Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways.
    Lu Q, Huang H, Wang X, Luo L, Xia H, Zhang L, Xu J, Huang Y, Luo X, Luo J.
    Pharmacol Res; 2023 May 22; 191():106760. PubMed ID: 37023991
    [Abstract] [Full Text] [Related]

  • 20. Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway.
    Zhang Y, Li N, Li H, Chen M, Jiang W, Guo W.
    BMC Pharmacol Toxicol; 2023 Mar 28; 24(1):20. PubMed ID: 36978114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.